Search Results - "Parihar, Ashutosh S."
-
1
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition
Published in International journal of molecular sciences (01-03-2023)“…Anti-neoplastic agents for cancer treatment utilize many different mechanisms of action and, when combined, can result in potent inhibition of cancer growth…”
Get full text
Journal Article -
2
A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers
Published in International journal of molecular sciences (08-07-2022)“…STAT3 and KRAS regulate cell proliferation, survival, apoptosis, cell migration, and angiogenesis. Aberrant expression of STAT3 and mutant active forms of KRAS…”
Get full text
Journal Article -
3
Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3
Published in Breast cancer : basic and clinical research (01-01-2018)“…Background: The serendipitous discovery of heavy-chain antibodies devoid of light chains in camelids and the subsequent development of VHHs (variable region of…”
Get full text
Journal Article -
4
The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: Synthesis and structure-activity relationships of 2-amino-4-azaindoles
Published in Bioorganic & medicinal chemistry letters (16-06-2003)“…2-Amino-4-azaindoles have been identified as a structurally novel class of BK(Ca) channel openers. Their synthesis from 2-chloro-3-nitropyridine is described…”
Get full text
Journal Article -
5
Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation
Published in European journal of pharmacology (27-06-2003)“…The effects of 1-ethyl-2-benzimidazolinone (1-EBIO) and riluzole on human prostate cancer cells, LNCaP and PC-3, were evaluated using rubidium (86Rb(+)) efflux…”
Get full text
Journal Article -
6
Functional analysis of large conductance Ca2(+)-activated K(+) channels: ion flux studies by atomic absorption spectrometry
Published in Assay and drug development technologies (01-10-2003)“…Although techniques such as (86)Rb(+) flux provide a sensitive measure of K(+) channel activity, the relatively short half-life and high-energy emission,…”
Get more information
Journal Article -
7
Automated Parallel Oocyte Electrophysiology Test station (POETs): a screening platform for identification of ligand-gated ion channel modulators
Published in Assay and drug development technologies (01-10-2003)“…Ligand-gated ion channels (LGICs) play important roles in the regulation of cellular function and signaling and serve as excellent drug targets. However, fast…”
Get more information
Journal Article -
8
Single domain antibody (SBT-100) crosses the blood brain barrier (BBB) and inhibits human glioblastoma by selectively targeting KRAS and P-STAT3
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e13547 Background: Glioblastoma is difficult to treat malignancy that has a high incidence of KRAS mutations ( > 90%) and hyper-expression of…”
Get full text
Journal Article -
9
Effect of KRAS and P-STAT3 inhibition by SBT-100 on gemcitabine and pancreatic cancer growth in vivo
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e15727 Background: Over 90% of pancreatic cancers have KRAS mutations and hyper-expression of P-STAT3 oncoproteins, which if specifically…”
Get full text
Journal Article -
10
A novel single domain antibody (sdAb) SBT-100 targeting intracellular STAT3 to inhibit major subtypes of human breast cancer
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
11
A novel single domain antibody (sdAb) SBT-100 to target intracellular STAT3 to affect growth and regression of human triple negative breast cancer (TNBC) cells
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
12
Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract STAT3 is involved in the pathogenesis of many malignancies, so we developed an anti-STAT3 VHH (variable region of the heavy chain), SBT-100, that…”
Get full text
Journal Article -
13
High throughput electrophysiology using a fully automated, multiplexed recording system
Published in Receptors & channels (2003)“…The drug discovery process centers around finding and optimizing novel compounds active at therapeutic targets. This process involves direct and indirect…”
Get more information
Journal Article -
14
Species-related pharmacological heterogeneity of histamine H3 receptors
Published in European journal of pharmacology (01-12-2001)Get full text
Journal Article -
15
Species-related pharmacological heterogeneity of histamine H 3 receptors
Published in European journal of pharmacology (21-12-2001)“…We compared radioligand binding and functional data for histamine H 3 receptor ligands across different tissues or species to evaluate the basis for…”
Get full text
Journal Article -
16
Effects of intermediate-conductance Ca 2+-activated K + channel modulators on human prostate cancer cell proliferation
Published in European journal of pharmacology (2003)“…The effects of 1-ethyl-2-benzimidazolinone (1-EBIO) and riluzole on human prostate cancer cells, LNCaP and PC-3, were evaluated using rubidium ( 86Rb +) efflux…”
Get full text
Journal Article -
17
The discovery of a new class of large-conductance Ca 2+-activated K + channel opener targeted for overactive bladder: synthesis and structure–activity relationships of 2-amino-4-azaindoles
Published in Bioorganic & medicinal chemistry letters (2003)“…2-Amino-4-azaindoles have been identified as a structurally novel class of BK Ca channel openers. Their synthesis from 2-chloro-3-nitropyridine is described…”
Get full text
Journal Article